PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TRIPLE-NEGATIVE BREAST CANCER

The present invention relates to a compound represented by chemical formula 1 in the present specification, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising a chemotherapeutic agent, wherein the pharmaceutical composition can be effectively used in the preve...

Full description

Saved in:
Bibliographic Details
Main Authors LIM, Kwon Jo, PARK, Joon Seok, KIM, Ji Duck, KWON, Ahreum
Format Patent
LanguageEnglish
French
Korean
Published 06.07.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a compound represented by chemical formula 1 in the present specification, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising a chemotherapeutic agent, wherein the pharmaceutical composition can be effectively used in the prevention or treatment of triple-negative breast cancer. La présente invention concerne un composé représenté par la formule chimique 1 dans la présente description, ou un sel pharmaceutiquement acceptable de celui-ci, et une composition pharmaceutique comprenant un agent chimiothérapeutique, la composition pharmaceutique pouvant être efficacement utilisée dans la prévention ou le traitement du cancer du sein triple négatif. 본 발명은 본 명세서의 화학식 1로 표기되는 화합물, 또는 이의 약학적으로 허용가능한 염, 및 화학요법제를 포함하는 약학적 조성물을 제공하는 것으로, 상기 약학적 조성물은 삼중음성유방암의 예방 또는 치료에 유용하게 사용할 수 있다.
Bibliography:Application Number: WO2022KR21693